Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Belitsky

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Transplantation|April 25, 2007
Can old be too old for kidney transplantation?Philip Belitsky
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 16, 2003
Advancing toward a modern death: the path from severe brain injury to neurological determination of deathSam D Shemie, Christopher Doig, Philip Belitsky
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2004
How to improve organ donation ratesSam D Shemie, Christopher Doig, Graeme Rocker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantationBryce A Kiberd, Joseph Lawen, Albert D Fraser, et al.
Urology|January 18, 2006
Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresisDharm Singh, Ken West, Khaled Kamal, et al.
Clinical Therapeutics|July 16, 2003
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001Stephen Pollard, Björn Nashan, Atholl Johnston, et al.
Transplantation|May 24, 2007
Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patientsClary J Foote, Wenda Greer, Bryce Kiberd, et al.
Pharmacoeconomics|July 13, 2004
An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantationPaul A Keown, Bryce Kiberd, Robert Balshaw, et al.
Clinical Transplants|May 18, 2006
The year in review--2004Philip Belitsky, Bjorn Nashan, Bryce Kiberd, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective studyKamran Mahalati, Philip Belitsky, Kenneth West, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Transplantation|April 25, 2007
Can old be too old for kidney transplantation?Philip Belitsky
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 16, 2003
Advancing toward a modern death: the path from severe brain injury to neurological determination of deathSam D Shemie, Christopher Doig, Philip Belitsky
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 6, 2004
How to improve organ donation ratesSam D Shemie, Christopher Doig, Graeme Rocker, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 16, 2004
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantationBryce A Kiberd, Joseph Lawen, Albert D Fraser, et al.
Urology|January 18, 2006
Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresisDharm Singh, Ken West, Khaled Kamal, et al.
Clinical Therapeutics|July 16, 2003
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001Stephen Pollard, Björn Nashan, Atholl Johnston, et al.
Transplantation|May 24, 2007
Polymorphisms of multidrug resistance gene (MDR1) and cyclosporine absorption in de novo renal transplant patientsClary J Foote, Wenda Greer, Bryce Kiberd, et al.
Pharmacoeconomics|July 13, 2004
An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantationPaul A Keown, Bryce Kiberd, Robert Balshaw, et al.
Clinical Transplants|May 18, 2006
The year in review--2004Philip Belitsky, Bjorn Nashan, Bryce Kiberd, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2001
Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective studyKamran Mahalati, Philip Belitsky, Kenneth West, et al.
Pageof 2